Skip to content
value.today

Meduloc, Inc.

Total raised
$6 M
3 rounds on record
Latest round
$2 M
Jul 2026
First round on record
Feb 2024
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Meduloc, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2026$2 MNo. 3Under $2 million

Meduloc, Inc.: Raise no. 3, Jul 2026

Investors in this round

2 investors had bought by the notice of Aug 6, 2026: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sarah Sachinis · Executive Officer, Director
  • Bruce Anderson · Director
  • Kim Brady · Director
  • Michael Collins · Director
  • Renu Parker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “No additional amounts will be paid to any such persons beyond what is due to those who are employees pursuant to the terms of their employment.”

Signed by Sarah Sachinis, Ceo. Source: SEC Form D, newest notice filed Aug 6, 2026. Read the notice at the SEC.

equity, optionsSEC
Feb 2026$2 MNo. 2$2 to $10 million

Meduloc, Inc.: Raise no. 2, Feb 2026

Investors in this round

11 investors had bought by the notice of Feb 17, 2026: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$250,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Sarah Sachinis · Executive Officer, Director
  • Bill Hagaman · Director
  • Bruce Anderson · Director
  • David Chersky · Director
  • Joshua Huesdt · Director
  • Kim Brady · Director
  • Michael Collins · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sarah Sachinis, Ceo. Source: SEC Form D, newest notice filed Feb 17, 2026. Read the notice at the SEC.

equity, optionsSEC
Feb 2024$2 MNo. 1Under $2 million

Meduloc, Inc.: Raise no. 1, Feb 2024

Investors in this round

10 investors had bought by the notice of Mar 7, 2024: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$250,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Alyson Ronald · Executive Officer
  • Benjamin Arnold · Executive Officer, Director
  • Michael Collins · Executive Officer, Director
  • Bruce Anderson · Director
  • Joshua Huesdt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Collins, Ceo. Source: SEC Form D, newest notice filed Mar 7, 2024. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Meduloc, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).

    SEC Form D · Aug 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2026

That is all the official record says: Meduloc, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Meduloc, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Meduloc, Inc.
NameRoleNamed in
Sarah SachinisExecutive officerAug 2026
Alyson RonaldExecutive officerMar 2024
Benjamin ArnoldExecutive officerMar 2024
Michael CollinsExecutive officerMar 2024
Bruce AndersonDirectorAug 2026
Kim BradyDirectorAug 2026
Michael CollinsDirectorAug 2026
Renu ParkerDirectorAug 2026
Sarah SachinisDirectorAug 2026
Bill HagamanDirectorFeb 2026
David CherskyDirectorFeb 2026
Joshua HuesdtDirectorFeb 2026
Benjamin ArnoldDirectorMar 2024